In this interview with Dr. Ruby Yanru Chen-Tsai, Chief Scientific Officer and Co-founder of Applied StemCell Inc. (ASC), we explore the company’s groundbreaking work at the intersection of gene-editing technologies and stem cell innovation. Based in Milpitas, California, ASC offers an optimized portfolio of tools for basic research, drug discovery, bioprocessing, bioproduction, and preclinical applications.
In this interview, we dive into Dr. Yanru Chen-Tsai’s background, ASC’s unique product portfolio, its TARGATT™ gene editing technology, and the company’s future trajectory. [Read more…]



